Concepedia

Publication | Open Access

Clinical manifestations of the anti-IgLON5 disease

402

Citations

9

References

2017

Year

Abstract

Patients with IgLON5 antibodies develop a characteristic sleep disorder preceded or accompanied by bulbar symptoms, gait abnormalities, oculomotor problems, and, less frequently, cognitive decline. IgG4 subclass antibodies predominate over IgG1; we confirm a strong association with the HLA-DRB1*10:01 allele.

References

YearCitations

1988

6.3K

2014

531

2016

232

2016

151

2015

69

2013

62

2013

61

2015

56

2010

51

Page 1